Trade-off of risk and benefit of finerenone across the spectrum of kidney function in patients with heart failure with mildly reduced and preserved ejection fraction in the FINEARTS-HF trial
19 May 2025 (13:55 - 14:05)
Organised by: 
Slides
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
6 More presentations in this session
Doctor A. Bhatt (San Francisco, US)
Doctor M. Karakas (Hamburg, DE)
Doctor K. Docherty (Glasgow, GB)
Access the full session
The Event
Heart Failure 2025
19 May 2025
13:55 CET
You may be interested in
Congress Presentation
Congress Presentation
